Cancer drug shows promise for rare skin disease
NCT ID NCT00479934
First seen May 18, 2026 · Last updated Jun 12, 2026 · Updated 6 times
Summary
This study tested the drug imatinib (Glivec) against a placebo in 28 adults with severe scleroderma, a disease that causes skin to harden and tighten. The goal was to see if imatinib could reduce skin thickness and improve quality of life. Participants took the drug or placebo for 6 months, and doctors measured changes using a skin score and biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA, LOCALIZED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Néphrologie et Médecine interne - CH de Valenciennes
Valenciennes, 59322, France
-
Service de Dermatologie - CHG Libourne
Libourne, 33500, France
-
Service de Dermatologie - CHG Périgueux
Périgueux, 24000, France
-
Service de Dermatologie - CHU de Toulouse - Hopital Purpan
Toulouse, 31059 Toulouse Cedex, France
-
Service de Dermatologie - service de médecine interne et vasculaire - hopital haut Lévêque - av.de magellan
Pessac, 33604, France
-
Service de Dermatologie et services de médecine interne et vasculaire - Hôpital St André - CHU de Bordeaux
Bordeaux, 33076, France
-
Service de Médecin interne - Hôpital central
Nancy, 54035, France
-
Service de Médecine interne - CHU de Tours
Tours, 37044, France
-
Service de Médecine interne - Hôpital Saint Louis
Paris, 75475, France
-
Service de Rhumatologie - CHU de Strasbourg
Strasbourg, 67098, France
-
Service de Rhumatologie, Hôpital Pellegrin-Tondu CHU de Bordeaux
Bordeaux, 33076, France
-
Service de dermatologie - CHU de Limoges
Limoges, 87042, France
Conditions
Explore the condition pages connected to this study.